Vagus nerve stimulation reduced inflammation and restored cognitive function after injury
For adults over age 65, surgical complications can dampen not only their physical health but also their mental sharpness, with more than half of high-risk cases declining into delirium.
In research published this week in the journal Brain Stimulation, Duke University scientists show in a mouse model that a current treatment for seizures can also reverse brain inflammation, such as inflammation after surgery, and the subsequent confusion or cognitive decline that results.
The therapy involves minimally invasive stimulation of the vagus nerve using small electrical pulses comparable to a cell phone’s vibrations.
The scientists used a Doppler ultrasound to guide the placement of a needle that delivers the electrical pulse, avoiding nearby delicate structures such as the carotid artery. Researchers hope to refine the technique into a completely non-invasive approach to preventing cognitive decline when seniors and other at-risk patients have surgery.
“Delirium is now recognized as the most common complication in older adults after surgery,” said Niccolò Terrando, Ph.D., associate professor of anesthesiology at Duke and the study’s senior author. “For most patients, it lasts a few days and resolves on its own. For some, it can lead to severe complications and even contribute to long lasting cognitive deficits, like dementia.”
Terrando noted that these cognitive complications have a huge impact on quality of life and can be expensive, with health care costs for delirium reaching $164 billion a year according to the American Society of Anesthesiologists.
“So far, there is no therapy for this kind of cognitive complication after surgery,” Terrando said. Anti-inflammatory drugs have many side effects and work broadly, he said, and they don’t adequately target the inflammation in the brain that scientists believe triggers cognitive complications.
The vagus nerve helps the brain communicate with the heart, lungs, gut and other parts of the body. Vagus nerve stimulators have been surgically implanted in epilepsy patients for more than 20 years to reduce seizures.
In recent years, U.S. doctors have also prescribed at-home, non-invasive stimulators for severe headaches. However, there is not substantial evidence that the devices are stimulating the vagus nerve and not other structures near it, said Warren M. Grill, Ph.D., professor of biomedical engineering at Duke.
For the experimental model, mice with inflammation received one nerve-stimulating treatment lasting several minutes. The researchers monitored for signs of vagus nerve activation, such as a slower heart rate and twitching of muscles around the larynx, and found improved cognitive outcomes and reduced brain inflammation after this treatment.
“This minimally invasive approach is already exceedingly benign, but in the long term it would be desirable to have an entirely non-invasive approach and we are beginning that work,” Grill said.
The Latest on: Vagus nerve stimulation
via Google News
The Latest on: Vagus nerve stimulation
- Implantable Vagus Nerve Stimulation Device Aids Weight Loss on December 19, 2018 at 4:32 am
An international team of researchers led by University of Wisconsin-Madison scientists has developed an easily implantable weight-loss device. In lab experiments, the device helped rats shed 38% of th... […]
- Targeting chemical signals between the gut and brain could lead to new treatment for obesity on December 18, 2018 at 5:02 pm
The researchers looked at the responses of the vagus nerve to normal meal stimulation. They found that in the mice with the high fat diet the nerve cells were less responsive and were less able to ... […]
- Incredible battery-free implant battles obesity by suppressing appetite on December 17, 2018 at 6:02 pm
A newer strategy that has arisen over the past few years is called vagus nerve stimulation (VNS). The vagus nerve is a large conduit that communicates signals between the brain and the body. […]
- EVFM Powered Up, AXON Gets A Boost, ARVN On Watch on December 17, 2018 at 4:17 pm
On November 28, the Company received FDA clearance for an expanded label for gammaCore [non-invasive vagus nerve stimulator (nVNS)] therapy for adjunctive use for the preventive treatment of ... […]
- Neuromodulation Devices Market Ready to Set Outstanding Growth at 11.2% CAGR And Top 10 Industry Players Comprehensive Analysis Till 2027 on December 17, 2018 at 4:53 am
deep brain stimulation devices (DBS), sacral nerve stimulation devices, Vagus nerve stimulation devices and Gastric electric stimulation devices. At Market Research Future (MRFR), we enable our custom... […]
- First Canadian child receives deep brain stimulation for drug-resistant epilepsy on December 12, 2018 at 8:01 pm
WATCH: Toronto baby receives Canada’s first in-utero spina bifida surgery After, they tried vagus nerve stimulation — a “pacemaker for the brain” that sends electrical pulses to the ... […]
- Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies on December 12, 2018 at 2:39 pm
Migraine affects 15% of the population in the United States and is associated with comorbidities, with an estimated economic burden of $78 billion annually. GammaCore is used adjunctively with current ... […]
- Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications on December 12, 2018 at 2:39 pm
GammaCore was cleared by the FDA for the acute treatment of episodic migraine and episodic cluster headache and has 5 Conformité Européenne marks. Data indicate that gammaCore treatment is both safe a... […]
- Noninvasive Neurostimulator Helps Prevent Cluster Headaches on December 12, 2018 at 10:41 am
A novel non-invasive vagus nerve stimulation (nVNS) device excites the nerve’s afferent fibers, leading to headache pain reduction. The electroCore (Basking Ridge, NJ, USA) gammaCore is hand-held adju... […]
via Bing News